Breakthrough Fusarium spp fungemia during caspofungin therapy in an ABO-incompatible orthotopic liver transplant patient

J Chemother. 2009 Apr;21(2):236-8. doi: 10.1179/joc.2009.21.2.236.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • ABO Blood-Group System
  • Amphotericin B / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Antifungal Agents / therapeutic use*
  • Bacterial Infections / drug therapy
  • Bacterial Infections / immunology
  • Caspofungin
  • Drug Therapy, Combination
  • Echinocandins / therapeutic use*
  • Female
  • Fungemia / drug therapy*
  • Fungemia / immunology*
  • Fusarium
  • Graft Rejection / prevention & control
  • Histocompatibility
  • Humans
  • Immunocompromised Host*
  • Immunosuppressive Agents / therapeutic use
  • Lipopeptides
  • Liver Transplantation / adverse effects*
  • Liver Transplantation / immunology
  • Meropenem
  • Middle Aged
  • Teicoplanin / administration & dosage
  • Thienamycins / administration & dosage

Substances

  • ABO Blood-Group System
  • Anti-Bacterial Agents
  • Antifungal Agents
  • Echinocandins
  • Immunosuppressive Agents
  • Lipopeptides
  • Thienamycins
  • liposomal amphotericin B
  • Teicoplanin
  • Amphotericin B
  • Caspofungin
  • Meropenem